期刊文献+

RNAi抑制Bmi-1基因表达对Jurkat细胞的影响(英文)

Down-regulation of Bmi-1 by RNA interference in Jurkat cells
下载PDF
导出
摘要 Objective: The aim of our study was to investigate the effects of down-regulation Bmi-1 by RNA interference (RNAi) in T Lymphocytic leukemia Jurkat cells. Methods: Two complementary oligonucleotide strands were synthesized based on the siRNA sequence targeting Bmi-1 gene. After annealing, siRNA strands were recombined into the pRNAT-U6.2 vector, and then DNA sequencing was carried out following transformation and amplification. The recombinant was transfected into Jurkat cells with liposomes. Positive colonies were obtained through G418 selection. The mRNA and protein expressions of Bmi-1 were detected by RT-PCR and Western-blot, respectively. Effects of Bmi-1 silence on cell proliferation, cell cycle and cell aging of Jurkat cells were detected by MTT assay, flow cytometry, colony formation assay and SA-β-Gal staining, respectively. Results: The siRNA recombinant targeting Bmi-1 gene was successfully constructed. All three siRNA recombinants could significantly inhibit the expression of Bmi-1. The siRNA targeting 825nt-843nt (GACCAGACCACTACT GAAT) has the strongest inhibitory effect on Bmi-1 expression, with almost complete inhibition on Bmi-1 mRNA and protein expressions. Compared with the non-transfection group and the empty vector group, growth velocity and colony formation ability were significantly decreased, while the proportion of cells in G1 phase and the percentage of senile cells were signifi-cantly increased in highly transfected group (P < 0.05). Conclusion: Down-regulation Bmi-1 by RNA interference (RNAi) could significantly inhibit the growth of Jurkat cells in vitro. Objective: The aim of our study was to investigate the effects of down-regulation Bmi-1 by RNA interference (RNAi) in T Lymphocytic leukemia Jurkat cells. Methods: Two complementary oligonucleotide strands were synthesized based on the siRNA sequence targeting Bmi-1 gene. After annealing, siRNA strands were recombined into the pRNAT- U6.2 vector, and then DNA sequencing was carded out following transformation and amplification. The recombinant was transfected into Jurkat cells with liposomes. Positive colonies were obtained through G418 selection. The mRNA and protein expressions of Bmi-1 were detected by RT-PCR and Western-blot, respectively. Effects of Bmi-1 silence on cell proliferation, cell cycle and cell aging of Jurkat cells were detected by M'l-r assay, flow cytometry, colony formation assay and SA-β-Gal staining, respectively. Results: The siRNA recombinant targeting Bmi.1 gene was successfully constructed. All three siRNA recombinants could significantly inhibit the expression of Bmi-l. The siRNA targeting 825nt-843nt (GACCAGACCACTACT GAAT) has the strongest inhibitory effect on Bmi-1 expression, with almost complete inhibition on Bmi-1 mRNA and protein expressions. Compared with the non-transfection group and the empty vector group, growth velocity and colony formation ability were significantly decreased, while the proportion of calls in G1 phase and the percentage of senile cells were signifi- cantly increased in highly transfected group (P 〈 0.05). Conclusion: Down-regulation Bmi-1 by RNA interference (RNAi) could significantly inhibit the growth of Jurkat cells in vitro.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2012年第12期732-736,共5页 中德临床肿瘤学杂志(英文版)
  • 相关文献

参考文献1

二级参考文献76

  • 1Schwartz YB and Pirrotta V. Polycomb complexes and epigenetic states. Curr Opin Cell Biol 2008, 20:266 273.
  • 2Orlando V. Polycomb, epigenomes, and control of cell identity. Cell 2003, 112:599 606.
  • 3Alkema MJ, Bronk M, Verhoeven E, Otte A, van't Veer LJ, Berns A and van Lohuizen M. Identification of Broil-interacting proteins as constituents of a multimeric mammalian polycomb complex. Genes Dev 1997, 11:226 240.
  • 4Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJ and Van Lohuizen M, et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 2003, 23:389 401.
  • 5Vonlanthen S, Heighway J, Altermatt H J, Gugger M, Kappeler A, Bomer MM and van Lohuizen M, et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001, 84:1372 1376.
  • 6Zhang F, Sui L and Xin T. Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues. Exp Oncol 2008, 30:70 74.
  • 7Sawa M, Yamaamoto K, Yokozawa T, Kiyoi H, Hishida A, Kajiguchi T and Seto M, et al. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol 2005, 82:42-47.
  • 8Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL and Shao JY, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 66: 6225-6232.
  • 9Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M and Campisi J, et al. The Bmi-1 oncogene induces telo- merase activity and immortalizes human mammary epithelial cells.Cancer Res 2002, 62: 4736-4745.
  • 10Cui H, Hu B, Li T, Ma J, Alam G, Gunning WT and Ding HF. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol 2007, 170: 1370-1378.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部